Product: Cisatracurium Besylate Injection, 20 mg per 10 mL (2 mg per mL), For intravenous injection, 10 mL Multiple Dose Vial, Rx only, Fresenius Kabi USA, LLC  Lake Zurich, IL 60047, NDC 63323-417-10
Reason for recall: Incorrect/ Undeclared Excipient: Firm is recalling product due to an incorrect statement of Preservative free on the individual carton label.  The vial label and outer carton label contain the correct statement of 0.9% benzyl alcohol added as a preservative.
Recall initiated: 20160405
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated